titlesubmit dateissue date
Now showing items 1-17 of 17
A microbiota-based predictive model for type 2 diabetes remission induced by dietary intervention: From the CORDIOPREV study.
A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study
A set of miRNAs predicts T2DM remission in patients with coronary heart disease: from the CORDIOPREV study
Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene
Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects
Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study
Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain
Leisure-time physical activity, sedentary behaviors, sleep, and cardiometabolic risk factors at baseline in the PREDIMED-PLUS intervention trial: A cross-sectional analysis.
Mycophenolate Improves Brain-Gut Axis Inducing Remodeling of Gut Microbiota in DOCA-Salt Hypertensive Rats.
NLRP3 inflammasome suppression improves longevity and prevents cardiac aging in male mice
NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction
Probiotics Prevent Dysbiosis and the Rise in Blood Pressure in Genetic Hypertension: Role of Short-Chain Fatty Acids
Protective Effects of Short-Chain Fatty Acids on Endothelial Dysfunction Induced by Angiotensin II.
Self-renewing human bone marrow mesenspheres promote hematopoietic stem cell expansion
The metabolic and vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties.
Toll-like receptor 7-driven lupus autoimmunity induces hypertension and vascular alterations in mice.
Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study